source
- Prime Medicine clears legal hurdle with Beam Therapeutics, moves AATD gene therapy toward clinicPrime Medicine announced it will advance its AATD gene editing candidate into clinical trials after arbitrators ruled in its favor in a dispute with Beam Therapeutics. The dispute centered on a 20…
- AstraZeneca and GSK strike new China partnerships with Sino BiopharmSino Biopharm announced two separate agreements with the United Kingdom's largest drugmakers, AstraZeneca and GSK, to deepen their presence in the Chinese market. AstraZeneca will license rights t…